Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 810-688-1 | CAS number: 14034-59-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
An oral LD50 of 1410 mg/kg bw for p-toluenesulhonate and an oral LD50 of 841 mg/kg bw for ethylenediamine (both constituents of ethylenediamine p-toluenesulphonate) were determined in two acute oral toxicity studies.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 841 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
No studies on acute oral toxicity of ethylenediamine p-toluenesulphonate were available. However, Article 13 of REACH states that, in case no appropriate animal studies are available for assessment, information should be generated whenever possible by means other than vertebrate animal tests, i.e. applying alternative methods such as in vitro tests, QSARs, grouping and read-across. Two acute oral toxicity studies of the two constituents p-toluenesulphonate and ethylenediamine are available.
Five Sprague-Dawley rats per sex per dose were exposed to 316, 464 or 681 mg/kg bw ethylenediamine dissolved in water via oral gavage (BASF 1979). Ten Sprague-Dawley rats per sex per dose were exposed to 825, 1000, 1250 or 1470 mg/kg. After an observation period of 14 days the surviving animals were necropsied. Dyspnea, spasmodic respiration, apathy, abnormal position, staggering, spastic gait, orange-yellow urine, piloerection, diarrhea, cyanosis, exsiccosis, salivation, blood in the feces and a poor general condition were observed amongst exposed animals. Acute dilation on the right side and acute congestion of the heart, diffuse reddening of the glandular stomach, diarrheal content, atonic and reddened intestine in several cases, and extensive hemorrhages of the thymus were observed amongst animals that died upon necropsy. In several sacrificed animals a slightly indurated forestomach and adhesion of the forestomach to the liver were observed upon necropsy. The LD50 was determined to be 841 and 893 mg/kg bw for male and female rats, respectively. The LD50 was determined to be 866 mg/kg bw for male and female animals combined.
In an OECD 401 guideline study, performed according to GLP, five female Wistar rats per dose were exposed to 1250, 1600 and 2000 mg/kg bw p-toluenesulphonate dissolved in water via oral gavage (Hoechst 1988). An additional five male Wister rats were exposed to 2000 mg/kg bw. After an observation period of 28 days the surviving animals were necropsied. Decreased spontaneous activity, crouching, reduced size flanks, irregular breathing, uncoordinated gait, long legged gait, staggering gait, blepharophimosis, ruffled fur, lacrimation, lying in the prone or lateral position, crawling-like movement forward, decreased proprioceptive reflex, miosis, diarrhea, hypersensitive to touch and a swollen abdomen were observed among the exposed animals. During gross pathology abnormalities were detected in the liver, lung, gastrointestinal tract, spleen and adrenal glands. Two out of five male animals exposed to 2000 mg/kg bw died. For the female animals the LD50 was determined to be 1410 mg/kg bw.
Justification for selection of acute toxicity – oral endpoint
Two acute oral toxicity studies are available. Each study is performed with one of the two components of ethylenediamine p-toluenesulphonate. The lowest LD50 is used for classification and labeling
Justification for classification or non-classification
Based on an oral LD50 of 1410 mg/kg bw for p-toluenesulphonate and an oral LD50 of 841 mg/kg bw for ethylenediamine, which are both constituents of ethylenediamine p-toluenesulphonate, ethylenediamine p-toluenesulphonate has to be classified for Acute toxicity Cat 4: H302: Harmful if swallowed in accordance with EU Classification, Labeling and Packaging of Substances and Mixtures (CLP) Regulation No. 1272/2008 and Xn R22: Harmful is swallowed in accordance with EU Directive 67/548 (DSD).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.